No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-23 | INmune Bio Is A High-Potential Opportunity, But Here's Why I'm Waiting · seeking_alpha |
| 2026-10-21 | INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027 · globe_newswire |
| 2026-10-21 | INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar · markets.businessinsider.com |
| 2026-10-21 | INmune Bio submits pre-approval package to UK regulator for RDEB · investing_com |
| 2026-10-21 | INmune Bio partners with Uniphar for Ebstrocel distribution · investing_com |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。